MedTrace Logo

Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety Disorders

NCT01643642 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 182

Last updated 2013-06-11

No results posted yet for this study

Summary

This study compares both clinical effectiveness and cost-effectiveness of a brief, intensified therapy and diagnostic method for patients with mood and/or anxiety disorders with Treatment As Usual (TAU) at five outpatient Mental Healthcare Centers in the Netherlands.

Conditions

  • Depressive Disorder
  • Anxiety Disorder

Interventions

OTHER

Cognitive behavioral treatment/farmacotherapy intervention

Brief cognitive behavioral intervention/farmacotherapy; intake, treatment and ROM

OTHER

Treatment As Usual

Other: Treatment As Usual

Sponsors & Collaborators

  • GGZ Rivierduinen

    collaborator OTHER

  • Leiden University Medical Center

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Netherlands

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01643642 on ClinicalTrials.gov